Management reiterated 2025 revenue guidance of $17 million to $18 million, which represents 24% growth at the midpoint over 2024. Horn stated, "Our guidance range assumes our customers will continue ...

Revenue: $4.2 million for Q1 2025, a 37% increase from $3.1 million in Q1 2024. Product Revenue: $2.9 million, including $5,000 from related parties. Service Revenue: $1.2 million, including $47,000 ...

Good day, and thank you for standing by. Welcome to Seer first quarter 2025 earnings conference call. At this time all participants are in a listen-only mode. After the speaker's presentation, there ...

If you’re looking at an image of a cell or tissue that’s stained or glowing, there’s a good chance that the signal you’re observing hails from a protein. For years, ligands such as antibodies and ...

Seer, which provides a proteograph product suite for biomedical research, filed on Thursday with the SEC to raise up to $150 million in an initial public offering. The company aims to commercialize ...

Seer has actively engaged in a share repurchase program, buying back approximately $22 million of Class A common shares. This move has reduced the net total shares outstanding by about 14%, reflecting ...

At this year’s American Society for Mass Spectrometry (ASMS) conference in Baltimore, Seer unveiled its latest advancement – the new Proteograph® Product Suite featuring the Proteograph ONE Assay and ...

Seer, Inc. ((SEER)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call of Seer, Inc. painted a picture of both achievements and hurdles. The company ...